Open AccessClinical and Cost Efficacy of Advanced Wound Care Matrices for Venous Ulcers
Author(s) -
Cheryl S. Hankin,
J. Knispel,
Maria Helena Itaqui Lopes,
Amy Bronstone,
Erik A. Maus
Publication year - 2012
Publication title -
journal of managed care pharmacy
Language(s) - English
Resource type - Journals
eISSN - 1944-706X
pISSN - 1083-4087
DOI - 10.18553/jmcp.2012.18.5.375
Subject(s) - medicine , number needed to treat , formulary , compression therapy , randomized controlled trial , clinical trial , venous leg ulcer , wound care , intensive care medicine , cost effectiveness , physical therapy , surgery , confidence interval , relative risk , family medicine , risk analysis (engineering)
In the United States, venous leg ulcers (VLUs) are commonly associated with substantial disability, impaired quality of life, and high economic costs. Compression therapy, which has remained the standard care for VLUs over several decades, is often insufficient to heal VLUs in a timely manner. VLU-related treatment costs are directly related to time to achieve complete wound closure. Advanced wound care matrices (AWCMs) developed to stimulate wound healing may reduce VLU-related costs associated with delayed healing. Randomized controlled trials (RCTs) have evaluated the wound-healing efficacy of several AWCMs in patients with VLUs. However, comparisons of products' clinical and cost efficacy, which may guide clinical and formulary determinations, are lacking.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom